Rare Wolf Capital’s Merck MRK Stock Holding History

Rare Wolf Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.75M	Sell	13,596 -1,653	-11%	-$193K	1.12%	23
2026 Q1	$1.83M	Sell	15,249 -8,180	-35%	-$944K	1.19%	19
2025 Q4	$2.47M	Buy	+23,429	New	+$2.2M	1.54%	10

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Rare Wolf Capital's MRK Position: Q2 2026 in Review

Rare Wolf Capital reduced its Merck (MRK) stake by 11% in Q2 2026, selling an estimated $193K and leaving 13,596 shares worth $1.75M. The position accounts for 1.12% of the portfolio, ranked #23.

Rare Wolf Capital first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.47M in Q4 2025. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Rare Wolf Capital held 13,596 shares of Merck worth $1.75M as of Q2 2026.
Rare Wolf Capital sold 1,653 Merck shares in Q2 2026, an estimated $193K.
Merck made up 1.12% of Rare Wolf Capital's portfolio in Q2 2026, its #23 holding.
Rare Wolf Capital first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
Rare Wolf Capital's Merck position peaked at $2.47M in Q4 2025.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Rare Wolf Capital's 13F filing for Q2 2026, filed 24 Jul 2026.